Exact Sciences to Participate in December Investor Conferences
MADISON, Wis.–(BUSINESS WIRE)–
Exact Sciences Corp. (Nasdaq: EXAS), a leading provider of cancer screening and diagnostic tests, today announced that company management will participate in the following conferences and invited investors to participate by webcast.
-
Citi Global Healthcare Conference, Miami
Fireside chat on Tuesday, December 3, 2024 at 8:45 a.m. ET
-
Evercore HealthCONx Conference, Miami
Fireside chat on Wednesday, December 4, 2024 at 7:30 a.m. ET
The webcasts can be accessed in the investor relations section of Exact Sciences’ website at www.exactsciences.com.
About Exact Sciences Corp.
A leading provider of cancer screening and diagnostic tests, Exact Sciences gives patients and health care professionals the clarity needed to take life-changing action earlier. Building on the success of the Cologuard® and Oncotype® tests, Exact Sciences is investing in its pipeline to develop innovative solutions for use before, during, and after a cancer diagnosis. For more information, visit ExactSciences.com, follow Exact Sciences on X @ExactSciences, or find Exact Sciences on LinkedIn and Facebook.
View source version on businesswire.com: https://www.businesswire.com/news/home/20241126529613/en/
Erik Holznecht
Exact Sciences Corp.
[email protected]
608-800-6605
KEYWORDS: Wisconsin United States North America
INDUSTRY KEYWORDS: Oncology Medical Supplies Health Medical Devices Other Health General Health Biotechnology
MEDIA:
| Logo |
 |